3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Sell
38
ACRV Quote, Financials, Valuation and Earnings
Last price:
$6.73
Seasonality move
:
28.76%
Day range:
$6.48 - $7.18
52-week range:
$3.19 - $11.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.07x
Volume:
45.3K
Avg. volume:
56.9K
1-year change:
48.9%
Market cap:
$211.4M
Revenue:
--
EPS (TTM):
-$2.71
Earnings Data
Next earnings date for ACRV
Mar 28
2025
Most recent earnings per share
-$0.59
Beat by $0.00
(Nov 13/2024)
Consensus Estimate
-$0.59
(Nov 13/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ACRV Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | -- | -- | -- | -$0.71 | -- |
| 03/28/2025 | Q4 | -- | -- | -- | -$0.70 | -- |
| 11/13/2024 | Q3 | -- | -- | -$0.59 | -$0.59 | $0.00 |
| 08/13/2024 | Q2 | -- | -- | -$0.52 | -$0.57 | $0.05 |
| 05/14/2024 | Q1 | -- | -- | -$0.73 | -$0.83 | $0.10 |
| 03/28/2024 | Q4 | -- | -- | -$0.87 | -$0.69 | -$0.18 |
| 11/09/2023 | Q3 | -- | -- | -$0.66 | -$0.69 | $0.03 |
| 06/30/2023 | Q2 | -- | -- | -$0.63 | -$0.62 | -$0.01 |
| 03/31/2023 | Q1 | -- | -- | -$0.58 | -$0.62 | $0.04 |
| 12/31/2022 | Q4 | -- | -- | -$0.80 | -$0.81 | $0.01 |
| 09/30/2022 | Q3 | -- | -- | -$0.49 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.45 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.56 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.34 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.19 | -- | -- |
Acrivon Therapeutics Earnings Questions
-
How Much did Acrivon Therapeutics Generate in Revenue Last Quarter?
Acrivon Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Acrivon Therapeutics Beat Earnings Last Quarter?
Acrivon Therapeutics announced earnings per share of -$0.59 which represents a beat of analyst forecast a -$0.59 per share.
-
Is Acrivon Therapeutics Profitable?
Acrivon Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Acrivon Therapeutics EPS Next Year?
Acrivon Therapeutics's earnings are forecast to decrease from -$2.74 per share to -$2.63 per share next year representing a decrease of -4.14%.
-
When is Acrivon Therapeutics's Earnings Date?
Acrivon Therapeutics's next earnings date is March 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Will Booking Holdings Stock Split?
Booking Holdings, the travel and technology company that owns brands…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 30.64% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is up 22.41% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is up 18.99% over the past day.
